chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt's MRI of cervical cord showed degenerative osteophytic changes-cervical cord compression @ C6-7; foraminal narrowing; EMG showed denervation; spinal fluid @ the time of meylogram showed a protein of 127; weakness of lt arm;
Swelling in arm at the point of inoculation, right deltoid. I developed a cough and feeliing of heaviness in my chest.  Swelling migrated down my arm to the elbow and then to my forearm, and then to hands and fingers.  I experience further swelling in my shoulder and under my arm, in my arm pit area.  The swelling made my arm hot, hard, and very sore.  I developed a fever of over 102 degrees. The hospital personnel would not take any blood for tests from this arm.  The swelling started immediately and continued over the course of five days, 07 Aug 2007 to 11 Aug 2007.  10/10/2007 MR received for DOS 8/7-10/2007 for D/C DX of:  1. Fever, questionable 2' to colitis, pneumonia, rxn to Pneumovax with cellulitis, gallbladder disease, or ideopathic.  2. Peptic Ulcer disease associated w/ NSAID use. 3. Abdominal pain, questionable 2' to #2 vs colitis.  4. Hypotension thought 2' to dehydration and possibly infection.  5.  Diarrhea, resolved.  6. Gallbladder dysfunction seen on HIDA scan 3/2007.  7. Asthma.  8.  Migraine Headache.  9. Hypothyroidism.  10.  Adverse reaction to Pneumovax with mild cellulitis of the R upper extremity.  Pt presented to ER with c/o abdominal and chest pain and was admitted for w/u of that.  Pt received Pneumovax at time of admission.  Pt had ongoing pain and swelling of the RUE.  Pt had fevers but they were present prior to Pneumovax. Remainder of MR pertains to admission for Abd/Chest pain.
Patient called 48 hours after receiving the vaccination complaining of a swollen red area about 6 inches in diameter and feels like a hard lump on the injection site.
sore arm; This is a spontaneous report from a contactable consumer, reporting for herself. A 57-year-old female non-pregnant patient received the first dose of the bnt162b2 (BNT162B2; Lot Number: EN6206), via an unspecified route of administration on 08Mar2021 at 16:00 in the left arm at a single dose for covid-19 immunisation. The patient received the vaccinations in a health clinic/administration facility. The medical history was not reported. There were no allergies to medications, food, or other products. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]); biotin (BIOTIN). No other vaccinations administered within 4 weeks prior to bnt162b2 vaccination. On 31Mar2021, the patient experienced sore arm for 1 day, which were non-serious. There was no treatment given in response to the event. There was no covid prior to or post bnt162b2 vaccination. The clinical outcome of the event not recovered.  No follow-up attempts are required. No further information is expected.
pt recvd 2nd dose of vax on 9DEC91 & noted to have inc liver enzymes & exp an achy sensation which persisted for about 1 or 2 months;
6APR94 elevated temp 102; seizures 30-40sec; hospitalization;
Stroke twice Acute idiopathic spontaneous intraparenchymal intracerebral hemorrhage (CMS-HCC) Loss of vision in lower left quadrant
headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.   Reporter did not allow further contact
Within 6-7 hours of receiving the vaccine I developed muscle and joint aches and pain and extreme fatigue. I thought I had the flu, since I'd never before had a reaction to any vaccine. The symptoms lasted 12-15 hours.
Patient had already received Pfizer vaccine from another healthcare facility early in the year. She came in to pharmacy for a Covid test, but accidentally said Covid Vaccine. She filled out the screening questionnaire requesting the Moderna vaccine, which was then administered by the pharmacist on duty. Patient returned the next day and reported that she should not have been given the vaccine, rather a covid test.
pt recv vax 17OCT97 & 19OCT97 pt devel a rash & a couple of papules around the inj site & on the arms;pt afeb;21OCT97 pt was evaluated by MD who noted approx 20 lesion on the arm & trunk;
She became pale, limp, and jerking movement in head minutes after injections. Immediately alert, and oriented when moved to exam table and laid down. VS stable. Monitored x 20 min post injection.
Upon arriving in observation patient parked and began shaking. Patient advises this has happened in the past when he gave blood. Patient CAD x4. He denies complaint, advises he is "fine". HR 53 SpO2 97% BP 110/60 approximate time 1156.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 13-MAR-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). The vaccine was in excursion with a sum of hours of 16. The lowest recorded temperature was 33. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a nurse and described the occurrence of expired vaccine used in a female patient who received FLUARIX QUADRIVALENT (batch number XE294, expiry date 30th June 2014). On 30th September 2014, the patient received FLUARIX QUADRIVALENT. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. It was unknown if the reporter considered the expired vaccine used to be related to FLUARIX QUADRIVALENT. Additional information received on 30 September 2014: Nurse reported she gave 4 female adult patients an expired dose of flu vaccine. Additional information was either unavailable or not provided at time of report. This is one of the 4 reports received from the same reporter for the same vaccine.
Within 6 months my eyesight started to get blurry and I was very tired.  In April 2020 I checked my blood sugar and it was 454. My husband is a type 2 so he had the necessary equipment to test me. I immediately made a doctor appointment with Dr and she ran my A1C. It showed I had become a diabetic.
Per PCP - Three days following the initial dose of Pfizer Covid vaccine, the patient developed facial hives - only by night - that recurred 3 nights in a row and resolved without recurrence over the last 3 weeks. There was no associated general rash, respiratory, cardiovascular or gastrointestinal symptoms.  The history of the reaction does not suggest an immediate-type hypersensitivity reaction to the covid vaccine.
Syncope was observed; This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for 3 patients. This is the second of the 3 patients.  A female patient of an unspecified age received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced syncope was observed on an unspecified date between 6 months and 12 months ago. Event took place after use of product. The outcome was unknown.; Sender's Comments: Based on the information available, the Company cannot exclude that the suspect vaccine meningococcal group b rlp2086 contributed to the development of the reported event syncope.,Linked Report(s) : US-PFIZER INC-2019217296 Same reporter/drug/event, different patient;US-PFIZER INC-2019217421 Same reporter/drug/event, different patient
Death -coroner says enlarged heart & enlarge spleen  7/4/08 Reviewed PCP medical records of 1999-6/2008 which included vax record.  In 8/2007, c/o of tiredness & loss of appetite.  Monospot (-).  On day of vax, patient was well, weight noted as 237, otherwise no complaints. 7/8/08 Autopsy report states COD as arrhythmia due to cardiomyopathy.States anatomic findings of obesity, pulmonary edema, mild & left ventricular hypertrophy w/myocardial nuclear enlargement.  Patient had been found non-responsive by family.  EMS found patient cyanotic w/rigor & no further resuscitation was performed.  Family reported patient had been well earlier in the evening.  Albuterol inhaler was found at scene but no suspicious features at scene.
Information has been received from a pharmacist concerning a female who was vaccinated with her 1st dose of GARDASIL "recently". Subsequently the patient experienced rash on her body with itching. The rash were small fluid filled vesicles. The patient had sought medical attention and visited the office. She was recovering at the time of report. No further information is available.
Sore throat; Scratchy voice; Body aches; pain on the injection site; Headache; A spontaneous report was received from a 35-year-old healthcare professional, who was also the patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain on the injection site, headache, body aches, sore throat, and scratchy voice.   The patient's medical history was not provided.  No concomitant medications were reported.  On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Batch #025L20A) intramuscularly in her right deltoid for prophylaxis of COVID-19 infection.   On 30 Dec 2020, patient experienced pain on the injection site and a headache which resolved on 31 Dec 2020.  On 01 Jan 2021, the patient started having body aches.  On 02 Jan 2021, the patient experienced sore throat and scratchy voice.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, pain on the injection site and headache, was recovered/resolved on 31 Dec 2020.  The outcome of the events, body aches, sore throat, and scratchy voice, was not recovered/resolved.; Reporter's Comments: This case concerns a 35-year-old female who had nonserious events of unexpected Oropharyngeal pain and dysphonia and expected headache, pain, injection site pain.  Event onset occurred the same day as the first dose of mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Redness to right arm started 3/25/2004 from shoulder to elbow. Warm to touch. Cool compresses on after as possible. Benadryl TID for 2-3 days.
The patient experienced a sharp pain in his right arm upon any movement. he state it "feels like the bone is injured". No swelling,redness, discoloration or warth were noted at/around the injection site. There was nothing to palpitate.
Pt with mild headache, mild nausea, no vomiting, feeling tired since flu shot 2 days ago. Treatment is reassurance, symptomatic treatment of note, pt just finished an antibiotic last wk for unknown issue.
pt recvd vax & w/in 2hrs post vax exp scleritis then keratitis affecting the tear ducts causing the eyes to be red & dry;1wk later pt exp joint/pain/arthritis in hands;sx persist;the reporter-patient indicated that may need surgery;
Localized Hives in Left arm below vaccination site , approximately 4 to 5 " wide by 5-6" long with some noted wheezing the day of and first day after vaccination
Onset Headache morning after vaccine on the top of the head, back of head & neck. Numbness in Arms, Legs, Feet. Difficulty walking and grasping things and writing. Foggy Brain confusion & Memory and Vision change. Eye Pressure.
On 7/22/2016 I rec'd the shingles vaccine (ZOSTAVAX) from my doctor. Starting on the 25th I became very weak had a hard time staying awake. The 26th my lower legs (from the knees down) became extremely sore. I tried to push myself and ended up with an extremely sore back for a day. Now, 8/13/2016, I am still weak, my legs are still sore.
Two days after vaccination rash developed.  Initially it was localized to the injection site.  The rash gradually spread down to the inner side of her arm (same arm as vaccine).  At the vaccine site she developed erythematous papules that were itchy.  On 7/9/20 pt called in to on-call provider in the evening that she had developed a rash on her opposite arm on the inner side abouve her elbow and it was spreading up towards her axilla and back.  No shortness of breath, difficulty swallowing or breathing.  She was advised by the on-call provider to take Benadryl every 6 hours, start hydrocortisone 1% cream, and continue with the Claritin she has already been taking.  She was instructed to go to the ED if any difficulty breathing.  Early AM of 7/18/20 patient went to local ED for rash that had spread to both arms, lower back, and groin.  Still no difficulty breathing or tongue swelling or throat swelling.  In the ED she was diagnosed with urticaria.  She was given a prescription for hydroxyzine, told to continue Claritin, and add Pepcid as an adjunct.  On 7/21/20 follow-up call was made to patient.  She reported that she was doing much better with the hydroxyzine, rash had resolved, and no more itching.
Left side from hip down to her leg it was numb and swollen. She got the same feeling on the left side of her face all the way to the side of her mouth.
itchy bumps showing first on joints on hand and moving to joint of elbow where it is much larger
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 06-OCT-2012 11:05, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
vision problems, headache, facial numbness Hospitalization ,  Ophthalmologist Still have vision problems
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2016, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2016, the patient was treated by the same physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Pt received tetanus shot IM in L upper arm on 10/2/03. Post shot an area of red began to develop and slowly got bigger over time. Cellulitis. 3 1/2 x 3 inch erythematous region surrounding site of IM injection. The follow up received on 11/4/03 states pt received Tetanus shot IM in L deltoid on 10/2/03 post shot an area of erythema began to develop and slwoly got bigger (+) tenderness x 5d. Treated with antibiotic (name unk) and fully recovered. Td was routine booster.
Fever; body aches; nausea; vomiting; severe fatigue; headache; abdominal pain; site pain; This is a spontaneous report from a contactable consumer (patient herself). A 61-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# Ek5730), via an unspecified route of administration on 16Dec2020 16:15 in right arm at single dose for covid-19 immunization. Medical history included asthma, hypothyroidism, hyperlipidemia, allergies: codeine and sulfa. Prior to vaccination, the patient diagnosed with COVID-19. Concomitant medication included levothyroxine within 2 weeks of vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced fever, body aches, nausea, vomiting, severe fatigue, headache, abdominal pain and site pain on 17Dec2020 04:00 with outcome of recovering. All events were reported as non-serious. The patient received the treatment ondansetron (ZOFRAN) for events.
6/10/10: follow-up visits - red warm tender at injection site with pain.  6/18/10 - 1 1/2 inch diameter firm area, no redness, pain radiates thru shoulder and increases with movement.
pt recvd vax; pt devel candida infection following 1st dose of vax; pt failed to seroconvert following 3rd dose;
Her back was killing her; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Her back was killing her) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Her back was killing her). At the time of the report, BACK PAIN (Her back was killing her) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included Aleve and Advil; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case reported by a nurse and described the occurrence of dizziness in a 48 year old female pt who received hpe B vaccine. The pt's medical history was notable for Bipolar disorder. Concurrently the pt received lithium. On 1/27/04, the pt received the first dose of Engerix B (5465A6). Immediately following administration of Engerix B, the pt experienced dizziness, nausea, sweating, leg weakness, restlessness, taste disturbance, fatigue, and an injection site reaction characterized by injection site pain. Upon examination, the pt's blood pressure was 98/68 and her pulse was 65. Within twelve hours of the injection, on 1/27/04, the pt experienced a "roseola-like rash." On 1/29/04, the pt developed swollen glands and a rash on her face. The events were considered to jeopardize the pt and required intervention. The events were also associated with a potential product complaint. The vaccination series with Engerix B was discontinued. At the time of reporting, 2/24/04, the fatigue, swollen glands and facial rash were unresolved and all the other events resolved with unspecified sequelae. The nurse considered the events to possibly be related to vaccination with Engerix B.
To give context to the adverse event, in early November 2020 I was diagnosed with Bell's Palsy of unknown origin on the left side of my face. I was tested for COVID-19 and it came back negative. It resolved itself in about a month. About 8 hours after receiving the COVID-19 vaccine on 3/9/21 (about 6:30 p.m., I started to feel a slight headache. Because I had just had the vaccine, I was trying to avoid taking any pain medication, so I did not take anything for it. The headache got worse throughout the evening, and by 10 p.m. I would describe it as a moderate headache. It was primarily concentrated on the left side of my head towards the front, on my forehead and above the eyebrow. I went to bed without taking any pain medication. About 3 hours later, at about 1 p.m., I woke up, and the headache was much more intense. It felt like all the nerves around the left side of my face, including the nerve along my jaw line leading to the 7th cranial nerve that causes Bell's Palsy, were throbbing. I grew concerned about getting Bell's Palsy again, so at that time I took one ibuprofen Advil. After taking it, the headache subsided, although I continued to have a dull headache throughout the night and the next day. Patient received the vaccine Monday March 1st around 2:30pm. Patient began to feel arm soreness around 5pm, woke up at 3am the following morning with a severe headache and spent the next day resting. Wednesday morning March 3rd, the patient reported extreme fatigue, dizziness and feeling "woozy". As she was walking around the store, around 8:30am, patient had to request help as she almost fainted. Patient went home quickly after, reported dizziness until 3pm. Patient's friend who is a nurse came to her home to check her vitals, confirmed they were normal and encouraged fluids/rest. After resting further Wednesday/Thursday, patient returned to work Friday morning and has been fine since. Patient did not take any medications prior/during/after incident.
The patient received the second dose of Gardasil 9 one month after being vaccinated instead of the recommended two months; no adverse event; This spontaneous report as received from a consumer refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis. On an unknown date, the patient received the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) one month after being vaccinated instead of the recommended two months (inappropriate schedule of product administration). There was no adverse event. The outcome of inappropriate schedule of product administration was unknown.
TOOK ONLY ONE DOSE; TOOK DOXYCYCLINE WHILE ON VIVOTIF; This spontaneous case (PVX2019-905) was received from a nurse on 16-Apr-2019. It describes a 71-year-old elderly male consumer who "took only one dose" and "took doxycycline while on Vivotif". The consumer was receiving Vivotif for an unknown indication and doxycycline for Lyme disease exposure.   Case report: The consumer took a dose of Vivotif about 2.5 weeks ago from the date of report and then after few days (not more than two days), he had an exposure to Lyme disease. As a prophylaxis, he took doxycycline for 2 weeks.   Action taken with Vivotif and doxycycline was not applicable.  The clinical outcome of the events "took only one dose" and "took doxycycline while on Vivotif" was unknown.   Company's Comment: The causality of the event "took only one dose" and "took doxycycline while on Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only one dose" and "took doxycycline while on Vivotif" was considered as not applicable.
Fever shortness of breath, burning chest pain,  Narrative: Historically had MI age 31, Symptoms started 2 days after first dose and lasted about 5 days. Flu symptoms after second dose.